Method of treating a patient
View Patent ↗There is provided in accordance with an exemplary embodiment of the invention a method of treating diabetic patients comprising measuring a triglyceride level in a diabetic patient and applying a diabetes treatment according to the triglyceride level. Optionally, there is provided a method of screening. Alternatively or additionally, there is provided a method of weight loss. Alternatively or additionally, there is provided a method of relatively reducing HOMA-IR levels. Alternatively or additionally, there is provided a method of relatively reducing blood pressure. An exemplary device to apply the treatment is described.
1. A method of treating a patient for diabetes, comprising:
selecting a treatment for a patient with diabetes;
modifying the treatment according to a lipid level or a lipid indicator of said patient; and
applying said modified treatment to said patient.
2. A method according to claim 1 , wherein said lipid level comprises a plasma level.
3. A method according to claim 1 , wherein said lipid level comprises a hepatic level.
4. A method according to claim 1 , comprising estimating the lipid level.
5. A method according to claim 1 , wherein modifying the treatment comprises changing a timing of application of said treatment according to an expected change in lipid level.
6. A method according to claim 1 , wherein modifying the treatment comprises selecting a treatment type or one or more treatment parameters according to said lipid level.
7. A method according to claim 1 , wherein modifying the treatment comprises taking into account said lipid level when planning power usage.
8. A method according to claim 1 , wherein modifying the treatment comprises generating at least an indication to a patient to delay an activity and thereby allow the treatment to be applied at a lower lipid level.
9. A method according to claim 1 , wherein modifying the treatment comprises selecting a treatment parameter such that it overcomes or bypasses a control pathway blockage associated with said lipid.
10. A method according to claim 1 , wherein modifying the treatment comprises applying an additional treatment to reduce said lipid level or overcome a control-effect of said lipid level.
11. A method according to claim 1 , wherein said lipid level comprises an absolute lipid level.
12. A method according to claim 1 , wherein said lipid level comprises a relative lipid level.
13. A method according to claim 1 , wherein said lipid level comprises a change in lipid level.
14. A method according to claim 13 , wherein said change in lipid level comprises a reduction in triglycerides.
15. A method of treating a patient for diabetes, comprising modifying a lipid level of said patient according to a treatment to be applied.
16. A method according to claim 15 , wherein said modifying comprises modifying using a pharmaceutical.
17. A method according to claim 15 , wherein said modifying comprises modifying using electrical stimulation of an intrabody location.
18. A method according to claim 17 , comprising using a same set of electrodes for said treatment and for said modifying.
19. A method according to claim 17 , wherein modifying the treatment comprises taking into account said lipid level when planning power usage for said electrical stimulation.
20. A method according to claim 1 , wherein said lipid comprises triglycerides.
21. A method according to claim 1 , wherein said selecting a treatment comprises selecting a treatment for reducing blood glucose levels.
22. A method of treating a patient for diabetes, comprising:
determining a treatment to be applied to a patient with diabetes;
identifying a control pathway in the patient which interacts with said treatment;
modifying said control pathway of said patient according to said treatment to be applied; and
applying said treatment for said patient in addition to said modifying.
23. A method according to claim 22 , wherein said modifying comprises stimulating a vagal nerve.
24. A method according to claim 22 , wherein said modifying comprises modifying one or more parameter of said treatment so as to overcome a blockage in said pathway.
25. A method according to claim 22 , wherein said modifying comprises stimulating upstream of said blockage.
26. A method according to claim 22 , wherein said modifying comprises interfering with an input to said pathway.
27. A method according to claim 22 , wherein said modifying comprises perturbating said pathway.
28. A method according to claim 22 , wherein said modifying comprises causing reduction in triglyceride levels; and wherein said applying comprises applying said treatment after said reduction is achieved and with at least one parameter selected based on said reduction.
29. A method according to claim 28 , wherein said modifying comprises modifying by pharmaceutical and wherein said applying comprises electrically applying.
30. A method according to claim 22 , wherein said treatment comprises application of an electrical field to a part of the body.
31. A method according to claim 22 , wherein said treatment comprises application of an electrical field to a part of the GI tract.
32. A method according to claim 22 , wherein said treatment comprises pharmaceutical treatment.
33. A method of treating a patient for diabetes, comprising:
determining a treatment to be applied to a patient with diabetes;
identifying a control pathway in the patient having a blockage which interferes with said treatment;
selecting one or more treatment parameters to overcome said blockage; and
applying said treatment for said patient using said selected one or more parameters.
34. A method according to claim 33 , wherein identifying a pathway comprises identifying a pathway affected by a lipid.
35. A method according to claim 33 , wherein identifying a pathway comprises identifying a pathway affected by triglycerides.
36. A method according to claim 33 , wherein said treatment comprises application of an electrical field to a part of the body.
37. A method of treating a patient for diabetes, comprising:
selecting a treatment and at least one treatment parameter for a patient with diabetes according to a lipid level or a lipid indicator of said patient; and
applying said treatment with said at least one parameter to said patient.
38. A method according to claim 37 , wherein said lipid is one or more of triglycerides, HDL and LDL.
39. A method according to claim 38 , wherein said lipid comprises triglycerides.
40. A method according to claim 37 , wherein said treatment comprises application of an electrical field to a part of the body.